Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
But individuals who sought surgery soon after diagnosis had better outcomes.
Tecentriq after surgery and chemotherapy delayed recurrence in people with Stage II or III non-small-cell lung cancer.
Lumakras led to tumor shrinkage in 36% of NSCLC patients with KRAS G12C mutations.
Rybrevant is the first treatment for people with advanced non-small-cell lung cancer whose tumors have EGFR exon 20 insertion mutations.
The response rate was nearly 50% for people with breast, colon, pancreatic and other cancers.
More than 80% of lung cancer patients treated with the targeted therapy experienced remission or had stable disease.
Here are latest cancer drugs approved by the Food and Drug Administration.
The targeted therapy delayed disease progression in people with advance non-small-cell lung cancer, including those with brain metastasis.
The checkpoint inhibitor delayed disease progression and improved overall survival in non-small-cell lung cancer patients.
“Saved By the Bell” actor Dustin Diamond died Monday at age 44 from small cell lung cancer.
The new targeted therapy was approved for non-small-cell lung cancer with a specific MET mutation.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.